Sign In
Buy PPH
$110.40
-1.20 (-1.08%)
At Close: Jul 31, 2026
3 ETFs for the Healthcare Sector's Highs
05:53pm, Thursday, 27'th Oct 2022
Investors looking for equities suddenly have more than a few options to consider in this mini-market rally. Whether markets have really priced in Fed action or a possible recession already or not, inv
This ETF Is Home to Some of the Top Healthcare Stocks
01:59pm, Tuesday, 18'th Oct 2022
The healthcare sector isn't setting the investment world ablaze this year, but it is outperforming the broader market, underscoring its defense posture.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:32am, Tuesday, 18'th Oct 2022
Sector ETF report for PPH
PPH Investors Should Keep On Top Of Regulatory Developments
08:00am, Friday, 26'th Aug 2022
PPH investors own the whole world of bigger to big pharma, where wallet share is primarily in the U.S. Things are changing, however, with Medicare now able to negotiate prices with companies on the mo
What The Inflation Reduction Act Means For Drug Prices
01:24am, Friday, 26'th Aug 2022
The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:32am, Monday, 15'th Aug 2022
Sector ETF report for PPH
Pharma Stocks, ETFs Can Deal With Drug Pricing Legislation
08:49am, Wednesday, 27'th Jul 2022
This is a mid-term election year, meaning that some familiar issues investors should be aware of are popping up yet again. That includes reducing pharmaceutical prices.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:32am, Monday, 13'th Jun 2022
Sector ETF report for PPH
Pharma ETFs in Focus Post Q1 Earnings
12:48pm, Thursday, 12'th May 2022
Many industry bigwigs reported solid results with some beating on earnings or revenues or both.
PPH: A Pharmaceutical ETF Delivering Close To 10% Total Return
02:45pm, Wednesday, 13'th Apr 2022
Historically, PPH generated a steady total return with a low yield up to 2 percent. PPH's price multiples are considerably lower than its peers and index despite strong earnings and stable historical
Pharma In Transition: Context And Opportunities
02:32pm, Monday, 28'th Mar 2022
The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.
Solid Q4 Earnings Fail to Impress Pharma ETFs
01:50pm, Tuesday, 22'nd Feb 2022
Solid earnings failed to impress pharma ETFs over the past month due to a broad sell-off in the market.
Which ETFs Should Investors Be Watching Now? Our Favorite Is The IBB
10:55am, Tuesday, 15'th Feb 2022
Which ETFs Should Investors Be Watching Now? Our Favorite Is The IBB
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:42am, Tuesday, 08'th Feb 2022
Sector ETF report for PPH
Pharmaceuticals Stocks, ETFs Could Have Power Beyond 2022
11:09am, Friday, 04'th Feb 2022
Pharmaceuticals stocks and the related exchange traded funds are benefiting from the now-steady revenue stream provided by coronavirus vaccines, but with that priced into many pharmaceuticals equities
